Global topical drug delivery market is expected to reach USD 205.1 billion by 2024 from USD 101.7 billion in 2016, growing at a CAGR of 9.2% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
The global topical drug delivery market is segmented on the basis of product type, indication, distribution channel, end user and geography.
On the basis of product type the market is segmented into transdermal drug delivery devices and topical drug delivery formulations. Topical drug delivery formulations are further segmented based on form into solid, semi-solid and liquid.
For Sample Report: Global Topical Drug Delivery Market – Trends and Forecast to 2024
The topical drug delivery market is segmented on the basis of indications into 4 types such as acne, anesthetics, psoriasis, dermatitis & atopic dermatitis, rosacea, onychomycosis, alopecia, actinic keratosis, and others. In 2017, anti-acne is expected to dominate the market with the highest market share in the forecast period 2017 to 2024.
On the basis of end users the market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others. In 2017, the hospitals segment is expected to dominate the global topical drug delivery devices market with more than 40% market share.
Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.
To read more about the scope and findings of this report visit: Global Topical Drug Delivery market is growing at a significant rate in the forecast period 2017-2024
KEY PLAYERS OPERATING IN GLOBAL TOPICAL DRUG DELIVERY MARKET:
- Galderma Pharma, S.A.
- Allergen Plc. Kaken Pharmaceuticals, Co., Ltd
- Pfizer
- Bayer AG
- 3M
- Hisamitsu Pharmaceuticals, Co., Inc.
- Abbvie, Inc.
- Valeant Pharmaceuticals
- Antares Pharma
- MedPharm
- Janssen Pharmaceuticals, Inc. (A J&J Company)
- Crescita Therapeutics
- West Pharmaceutical Services
- Biofarmitalia s.r.l
- Pharmatek Laboratories, Inc.
- Stiefel Laboratories, Inc.
- Tapemark
- Acrux Limited
- Nitto Denko Corporation
- Skinvisible Pharmaceuticals, Inc.
- Mylan Pharmaceuticals Inc.
- Pocono Coated Products LLC
- TheraSolve NV.
- Samyang Biopharmaceuticals Corporation
- Lohmann Therapie-Systeme AG
- Prosollus Pharmaceuticals, Easton Pharmaceuticals Inc.
- Novosis AG
- Endo Pharmaceuticals Inc.
- Transdermal Technologies, Inc.
- Sheffield Pharmaceuticals, Inc.
- Solvay
Some of the major factors driving the topical drug delivery market are ability to deliver drug at the desired site, inter-and intra-patient variations, without fluctuations in drug levels, an enhanced suitability for self-medication and improved compliance. Also, increasing aging population, growing prevalence of skin related ailments and rising prevalence of chronic diseases, also new and better technologies for topical drug delivery is expected to boost the growth of this market are the major factors driving the growth of the injectable drug delivery market.
Enquire about the report: Global Topical Drug Delivery Market – Trends and Forecast to 2024
Table of Content:
1. INTRODUCTION
1.1. OVERVIEW OF THE GLOBAL TOPICAL DRUG DELIVERY MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. PRODUCT PIPELINE ANALYSIS
2.2.6. PORTER’S FIVE FORCES MATRIX
2.4. GLOBAL TOPICAL DRUG DELIVERY MARKET: RESEARCH SNAPSHOT
2.5. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL TOPICAL DRUG DELIVERY MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.1.1. RISING PREVALENCE OF CHRONIC DISEASE SUCH AS DIABETES
4.3.1.2. GROWTH IN TRANSDERMAL TECHNOLOGY
4.3.1.3. INNOVATION AND DEVELOPMENT OF NEW DRUG TYPES
4.3.1.4. BETTER HEALTHCARE SPENDING IN SOUTH ASIA AND AFRICA
4.3.2. RESTRAINTS
4.3.3. OPPURTUNITIES
4.3.4. THREATS
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. EXECUTIVE SUMMARY
6. TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. TOPICAL DRUG DELIVERY, BY PRODUCT TYPE
6.2.1. TRANSDERMAL DRUG DELIVERY DEVICES, BY PRODUCT TYPE
6.2.1.1. TRANSDERMAL PATCHES
6.2.1.2. TRANSDERMAL GELS
6.2.2. TOPICAL DRUG DELIVERY FORMULATIONS, BY FORM
6.2.2.1. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE
6.2.2.1.1. SOLUTIONS
6.2.2.1.2. SUSPENSIONS
6.2.2.2. SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE
6.2.2.2.1. GELS
6.2.2.2.2. CREAMS
6.2.2.2.3. OINTMENTS
6.2.2.2.4. PASTES
6.2.2.2.5. LOTIONS
6.2.2.3. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE
6.2.2.3.1. SUPPOSITORIES
6.2.2.3.2. POWDERS
7. TOPICAL DRUG DELIVERY MARKET, BY END-USER
7.1. OVERVIEW
7.2. HOSPITALS
7.3. HOME HEALTHCARE
7.4. CLINICS
7.5. DIAGNOSTIC CENTERS
7.6. OTHERS
8. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. HOSPITAL PHARMACIES
8.3. PHARMACY STORES
8.4. DIRECT TENDERS
8.5. ONLINE PHARMACY
9. TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE DRUG DELIVERY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
9.1.1. NORTH AMERICA
9.1.1.1. U.S.
9.1.1.2. CANADA
9.1.1.3. MEXICO
9.1.2. EUROPE
9.1.2.1. GERMANY
9.1.2.2. FRANCE
9.1.2.3. U.K.
9.1.2.4. ITALY
9.1.2.5. SPAIN
9.1.2.6. RUSSIA
9.1.2.7. TURKEY
9.1.2.8. BELGIUM
9.1.2.9. NETHERLANDS
9.1.2.10. SWITZERLAND
9.1.2.11. REST OF EUROPE
9.1.3. ASIA-PACIFIC (APAC)
9.1.3.1. JAPAN
9.1.3.2. CHINA
9.1.3.3. SOUTH KOREA
9.1.3.4. INDIA
9.1.3.5. AUSTRALIA
9.1.3.6. SINGAPORE
9.1.3.7. THAILAND
9.1.3.8. MALAYSIA
9.1.3.9. INDONESIA
9.1.3.10. PHILIPPINES
9.1.3.11. REST OF APAC
9.1.4. LATIN AMERICA
9.1.4.1. BRAZIL
9.1.4.2. REST OF LATIN AMERICA
9.1.5. MIDDLE EAST AND AFRICA
9.1.5.1. SOUTH AFRICA
9.1.5.2. REST OF MIDDLE EAST AND AFRICA
9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
10. TOPICAL DRUG DELIVERY MARKET: COMPETITIVE LANDSCAPE
10.1. GLOBAL TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS
10.2. U.S. TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS
10.3. EUROPE TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS
10.4. APAC TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS
10.5. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS
10.6. MIDDLE EAST AND AFRICA TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS
10.7. MERGERS & ACQUISITIONS
10.8. NEW PRODUCT DEVELOPMENT & APPROVALS
10.10. EXPANSIONS
10.10. REGULATORY CHANGES
10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
11. TOPICAL DRUG DELIVERY MARKET, COMPANY PROFILES
11.1. JANSSEN PHARMACEUTICALS, INC. (A J&J COMPANY)
11.1.1. COMPANY OVERVIEW
11.1.2. SWOT ANALYSIS
11.1.3. REVENUE ANALYSIS
11.1.4. PRODUCT PORTFOLIO
11.1.5. RECENT DEVELOPEMENTS
11.1.5. DATA BRIDGE ANALYSIS
11.2. CRESCITA THERAPEUTICS
11.2.1. COMPANY OVERVIEW
11.2.2. SWOT ANALYSIS
11.2.3. REVENUE ANALYSIS
11.2.4. PRODUCT PORTFOLIO
11.2.5. RECENT DEVELOPEMENTS
11.2.5. DATA BRIDGE ANALYSIS
11.3. GALDERMA S.A.
11.3.1. COMPANY OVERVIEW
11.3.2. SWOT ANALYSIS
11.3.3. REVENUE ANALYSIS
11.3.4. PRODUCT PORTFOLIO
11.3.5. RECENT DEVELOPEMENTS
11.3.6. DATA BRIDGE ANALYSIS
11.4. BIOFARMITALIA S.R.L
11.4.1. COMPANY OVERVIEW
11.4.2. SWOT ANALYSIS
11.4.3. REVENUE ANALYSIS
11.4.4. PRODUCT PORTFOLIO
11.4.5. RECENT DEVELOPEMENTS
11.4.5. DATA BRIDGE ANALYSIS
11.5. PHARMATEK LABORATORIES, INC.
11.5.1. COMPANY OVERVIEW
11.5.2. SWOT ANALYSIS
11.5.3. REVENUE ANALYSIS
11.5.4. PRODUCT PORTFOLIO
11.5.5. RECENT DEVELOPEMENTS
11.5.5. DATA BRIDGE ANALYSIS
11.6. STIEFEL LABORATORIES, INC.
11.6.1. COMPANY OVERVIEW
11.6.2. SWOT ANALYSIS
11.6.3. REVENUE ANALYSIS
11.6.4. PRODUCT PORTFOLIO
11.6.5. RECENT DEVELOPEMENTS
11.6.5. DATA BRIDGE ANALYSIS
11.7. TAPEMARK
11.7.1. COMPANY OVERVIEW
11.7.2. SWOT ANALYSIS
11.7.3. REVENUE ANALYSIS
11.7.4. PRODUCT PORTFOLIO
11.7.5. RECENT DEVELOPEMENTS
11.7.6. DATA BRIDGE ANALYSIS
11.8. NITTO DENKO CORPORATION
11.8.1. COMPANY OVERVIEW
11.8.2. SWOT ANALYSIS
11.8.3. REVENUE ANALYSIS
11.8.4. PRODUCT PORTFOLIO
11.8.5. RECENT DEVELOPEMENTS
11.8.6. DATA BRIDGE ANALYSIS
11.9. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
11.9.1. COMPANY OVERVIEW
11.9.2. SWOT ANALYSIS
11.9.3. REVENUE ANALYSIS
11.9.4. PRODUCT PORTFOLIO
11.9.5. RECENT DEVELOPEMENTS
11.9.6. DATA BRIDGE ANALYSIS
11.9. MYLAN PHARMACEUTICALS INC.
11.9.1. COMPANY OVERVIEW
11.9.2. SWOT ANALYSIS
11.9.3. REVENUE ANALYSIS
11.9.4. PRODUCT PORTFOLIO
11.9.5. RECENT DEVELOPEMENTS
11.9.6. DATA BRIDGE ANALYSIS
11.9. HISAMITSU PHARMACEUTICAL CO., INC.
11.9.1. COMPANY OVERVIEW
11.9.2. SWOT ANALYSIS
11.9.3. REVENUE ANALYSIS
11.9.4. PRODUCT PORTFOLIO
11.9.5. RECENT DEVELOPEMENTS
11.9.5. DATA BRIDGE ANALYSIS
11.10. THERASOLVE NV.
11.10.1. COMPANY OVERVIEW
11.10.2. SWOT ANALYSIS
11.10.3. REVENUE ANALYSIS
11.10.4. PRODUCT PORTFOLIO
11.10.5. RECENT DEVELOPEMENTS
11.10.6. DATA BRIDGE ANALYSIS
11.11. SAMYANG BIOPHARMACEUTICALS CORPORATION
11.11.1. COMPANY OVERVIEW
11.11.2. SWOT ANALYSIS
11.11.3. REVENUE ANALYSIS
11.11.4. PRODUCT PORTFOLIO
11.11.5. RECENT DEVELOPEMENTS
11.11.6. DATA BRIDGE ANALYSIS
11.12. LOHMANN THERAPIE-SYSTEME AG
11.12.1. COMPANY OVERVIEW
11.12.2. SWOT ANALYSIS
11.12.3. REVENUE ANALYSIS
11.12.4. PRODUCT PORTFOLIO
11.12.5. RECENT DEVELOPEMENTS
11.12.6. DATA BRIDGE ANALYSIS
11.13. PROSOLLUS PHARMACEUTICALS
11.13.1. COMPANY OVERVIEW
11.13.2. SWOT ANALYSIS
11.13.3. REVENUE ANALYSIS
11.13.4. PRODUCT PORTFOLIO
11.13.5. RECENT DEVELOPEMENTS
11.13.6. DATA BRIDGE ANALYSIS
11.14. EASTON PHARMACEUTICALS INC.
11.14.1. COMPANY OVERVIEW
11.14.2. SWOT ANALYSIS
11.14.3. REVENUE ANALYSIS
11.14.4. PRODUCT PORTFOLIO
11.14.5. RECENT DEVELOPEMENTS
11.14.6. DATA BRIDGE ANALYSIS
11.15. ANTARES PHARMA, INC.
11.15.1. COMPANY OVERVIEW
11.15.2. SWOT ANALYSIS
11.15.3. REVENUE ANALYSIS
11.15.4. PRODUCT PORTFOLIO
11.15.5. RECENT DEVELOPEMENTS
11.15.6. DATA BRIDGE ANALYSIS
11.16. ENDO PHARMACEUTICALS INC.
11.16.1. COMPANY OVERVIEW
11.16.2. SWOT ANALYSIS
11.16.3. REVENUE ANALYSIS
11.16.4. PRODUCT PORTFOLIO
11.16.5. RECENT DEVELOPEMENTS
11.16.6. DATA BRIDGE ANALYSIS
11.17. TRANSDERMAL TECHNOLOGIES, INC.
11.17.1. COMPANY OVERVIEW
11.17.2. SWOT ANALYSIS
11.17.3. REVENUE ANALYSIS
11.17.4. PRODUCT PORTFOLIO
11.17.5. RECENT DEVELOPEMENTS
11.17.6. DATA BRIDGE ANALYSIS
11.18. SHEFFIELD PHARMACEUTICALS, INC.
11.18.1. COMPANY OVERVIEW
11.18.2. SWOT ANALYSIS
11.18.3. REVENUE ANALYSIS
11.18.4. PRODUCT PORTFOLIO
11.18.5. RECENT DEVELOPEMENTS
11.18.6. DATA BRIDGE ANALYSIS
11.19. SOLVAY
11.19.1. COMPANY OVERVIEW
11.19.2. SWOT ANALYSIS
11.19.3. REVENUE ANALYSIS
11.19.4. PRODUCT PORTFOLIO
11.19.5. RECENT DEVELOPEMENTS
11.19.6. DATA BRIDGE ANALYSIS
11.20. 3M DRUG DELIVERY SYSTEMS
11.20.1. COMPANY OVERVIEW
11.20.2. SWOT ANALYSIS
11.20.3. REVENUE ANALYSIS
11.20.4. PRODUCT PORTFOLIO
11.20.5. RECENT DEVELOPEMENTS
11.20.6. DATA BRIDGE ANALYSIS
12. APPENDIX
13. ABOUT DATA BRIDGE MARKET RESEARCH
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Related Reports:
Global Radiopharmaceuticals Market – Industry Trends and Forecast to 2024
By Type (Diagnostic, Therapeutic), Procedural Volumes (Diagnostic Procedures, Therapeutic Procedures), Application, Sources (Nuclear Reactors, Cyclotrons), End User, Geography (North America, Europe, APAC, South America, MEA)– Industry Trends andForecast To 2024
Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Varsha Chaudhari
Email:Send Email
Phone: +1-888-387-2818
Address:Office Number 317, Amanora Chambers, Magarpatta Road, Hadapsar Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-topical-drug-delivery-market-trends-forecast-2024/
